10 completed, 2 active not recruiting, 2 recruiting. 14 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 10, Active not recruiting 2, Recruiting 2 |
| Phase 1 | 4 | Completed 4 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Desmoid Tumor: new trials by email Literature Review of Desmoid Tumor trials Research Report on Desmoid Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study in Adults With Desmoid Tumors ES014 - Desmoid Tumor | Phase 2 | Recruiting | Elpiscience (Suzhou) Biopharma, Ltd. | 50 | 2026-04-24 | 2026-10-21 |
| A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) Nirogacestat oral tablet - Desmoid Tumor, Aggressive Fibromatosis | Phase 2 | Active not recruiting | SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany | 20 | 2025-08-08 | 2026-09-15 |
| Study of Cryoablation and Nirogacestat for Desmoid Tumor Nirogacestat, Cryoablation - Desmoid Tumor | Phase 2 | Recruiting | Nam Bui | 28 | 2023-08-15 | 2026-09-10 |
| A Study of AL102 in Patients With Progressing Desmoid Tumors AL102, Placebo - Desmoid, Desmoid Tumor | Phase 2 / Phase 3 | Active not recruiting | Immunome, Inc. | 198 | 2021-09-01 | 2026-06-08 |
| A Study to Evaluate the Safety and Efficacy of Vactosertib and Imatinib in Patients With Advanced Desmoid Tumor vactosertib/imatinib combination - Desmoid Tumor | Phase 1 / Phase 2 | Completed | Hyo Song Kim | 24 | 2019-04-15 | 2024-05-13 |
| Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers Nab-Rapamycin, Nivolumab - Ewing Sarcoma, PEComa | Phase 1 / Phase 2 | Completed | Sarcoma Oncology Research Center, LLC | 34 | 2017-08-24 | 2025-02-17 |
| A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Sirolimus - Desmoid Tumor | Phase 1 / Phase 2 | Completed | MaineHealth | 9 | 2014-02-01 | 2023-06-26 |
| Study to Evaluate Imatinib in Desmoid Tumors Imatinib - Aggressive Fibromatosis, Desmoid Tumor | Phase 2 | Completed | Heidelberg University | 39 | 2010-06-01 | 2017-05-03 |
| Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas sunitinib malate - Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 53 | 2007-04-01 | 2016-01-20 |
| Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis imatinib mesylate - Desmoid Tumor | Phase 1 / Phase 2 | Completed | UNICANCER | 40 | 2004-09-01 | 2016-08-30 |
| Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor tamoxifen citrate, sulindac, laboratory biomarker analysis - Desmoid Tumor | Phase 2 | Completed | Children's Oncology Group | 70 | 2004-02-01 | 2020-02-19 |
| Radiation Therapy in Treating Patients With Aggressive Fibromatoses radiation therapy - Desmoid Tumor | Phase 2 | Completed | European Organisation for Research and Treatment of Cancer - EORTC | 44 | 2001-11-01 | 2013-08-27 |
| Vinblastine and Methotrexate in Treating Children With Desmoid Tumors methotrexate, vinblastine sulfate - Desmoid Tumor | Phase 2 | Completed | Children's Oncology Group | 28 | 1997-08-01 | 2014-07-25 |
| Toremifene in Treating Patients With Desmoid Tumors toremifene, conventional surgery - Desmoid Tumor | Phase 2 | Completed | Advocate Lutheran General Hospital | 72 | 1991-07-01 | 2013-07-10 |
Desmoid Tumors (14) · Sarcoma (2) · AIDS-related Kaposi sarcoma (1) · Bone Neoplasms (1) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Squamous Cell (1) · Carcinoma, Transitional Cell (1) · Chondrosarcoma (1) · Chondrosarcoma, Extraskeletal Myxoid (1) · Chordoma (1) · Colorectal Neoplasms (1) · Dermatofibrosarcoma (1) · Desmoplastic Small Round Cell Tumor (1)
Fibroma (14) · Neoplasms (14) · Neoplasms by Histologic Type (14) · Neoplasms, Connective Tissue (14) · Neoplasms, Connective and Soft Tissue (14) · Neoplasms, Fibrous Tissue (14) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms by Site (2) · Neoplasms, Bone Tissue (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Urogenital Diseases (2)
Imatinib Mesylate (2) · nirogacestat (2) · Cryosurgery (1) · Methotrexate (1) · Nivolumab (1) · Radiotherapy (1) · Sirolimus (1) · Sulindac (1) · Sunitinib (1) · Tamoxifen (1) · Toremifene (1) · Vinblastine (1) · vactosertib (1)
Children's Oncology Group (2) · Advocate Lutheran General Hospital (1) · Elpiscience (Suzhou) Biopharma, Ltd. (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Heidelberg University (1) · Hyo Song Kim (1) · Immunome, Inc. (1) · MaineHealth (1) · Memorial Sloan Kettering Cancer Center (1) · Nam Bui (1) · Sarcoma Oncology Research Center, LLC (1) · SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany (1) · UNICANCER (1)
United States (8) · Germany (3) · Australia (2) · Belgium (2) · France (2) · Netherlands (2) · Poland (2) · South Korea (2) · United Kingdom (2) · Canada (1) · China (1) · Israel (1) · Italy (1) · Japan (1) · Spain (1)
Aaron R Weiss, DO (1) · Bernd Kasper, PD Dr. med. (1) · Brian L. Samuels, MD (1) · Bruce Himelstein, MD (1) · Erlinda M Gordon, MD (1) · Jean-Yves Blay, MD, PhD (1) · Mary L. Keohan, MD (1) · Mrinal Gounder, MD (1) · Nam Bui, M.D. (1) · R. B. Keus, MD (1) · Robert Maki, MD, PhD (1) · Stephen Skapek, MD (1) · Steve Skapek, MD (1) · Thomas Schnabel, MD (1)
PMID 17290057, PMID 19451429, PMID 20622000, PMID 24089446, PMID 26861905, PMID 28282612, PMID 31401903
P30CA008748 (1), U10CA098543 (1)